Gaush Meditech Ltd — Governance Information 2026

Mar 26, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

高视 GAUSH

Gaush Meditech Ltd

高视医疗科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2407)

PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION

This announcement is made by Gaush Meditech Ltd (the "Company") pursuant to Rule 13.51(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") in relation to the proposed amendments to the sixth amended and restated memorandum and articles of association of the Company (the "Existing Memorandum and Articles of Association").

The board (the "Board") of directors (the "Director(s)") of the Company proposed to make the amendments to the Existing Memorandum and Articles of Association in order to align with the Core Shareholder Protection Standards set out in Appendix A1 to the Listing Rules which require, among others, the holding of general meetings at which shareholders can attend virtually with the use of technology and cast votes by electronic means (the "Proposed Amendments"), and to adopt the seventh amended and restated memorandum and articles of association of the Company incorporating and consolidating all the Proposed Amendments (the "New Memorandum and Articles of Association").

---

The Proposed Amendments and the adoption of the New Memorandum and Articles of Association are subject to the approval of the shareholders of the Company by way of a special resolution at the forthcoming annual general meeting (the “AGM”) to be convened and held by the Company. A circular containing, inter alia, details of the Proposed Amendments and the adoption of the New Memorandum and Articles of Association, together with a notice convening the AGM, will be published and/or despatched by the Company in due course.

By order of the Board

Gaush Meditech Ltd

Mr. Gao Tieta

Chairman and Executive Director

Hong Kong, March 26, 2026

As of the date of this announcement, the Board comprises Mr. Gao Tieta as Chairman and executive Director, Mr. Liu Xinwei, Mr. Zhao Xinli, Mr. Zhang Jianjun and Ms. Li Wenqi as executive Directors, Dr. David Guowei Wang as non-executive Director, and Mr. Feng Xin, Mr. Wang Li-Shin and Mr. Chan Fan Shing as independent non-executive Directors.

• 2 -